|
Getting your Trinity Audio player ready...
|
A bill that would rewrite how Alabama regulates hemp-derived THC products was carried over in committee on Wednesday after several substitutions.
Sponsored by Sen. Tim Melson, R-Florence, SB132 targets “psychoactive cannabinoids,” specifically Delta-8, Delta-9, and Delta-10 derivatives. If passed, the bill would classify THC in hemp products as Schedule 1 controlled substances, similar to heroin or LSD.
While the Senate Healthcare Committee has not yet voted on the bill, it has discussed potential revisions. One key revision would impose stricter penalties on those selling psychoactive cannabinoids to minors.
The bill now proposes a $1,500 fine for a first offense, $2,500 for a second and $5,000 for a third. A fourth violation would result in the revocation of a retailer’s license to sell age-restricted products, including tobacco and alcohol.
The revision includes age restrictions, limiting sales to individuals 21 and older and requiring products to be stored out of reach of children. The bill would also mandate that hemp-derived THC products be made in Alabama and undergo safety testing.
Originally, the bill sought to classify Delta-8 and similar cannabinoids as Schedule 1 controlled substances, but the revised version proposes a 6 percent additional tax on these products, keeping them legal while regulating their sale.
The bill was carried over in the Senate Committee on Healthcare.
